Literature DB >> 23791694

Differential immune modulation by deoxynivalenol (vomitoxin) in mice.

Mohammad Rafiqul Islam1, Yoon Seok Roh1, Jinho Kim2, Chae Woong Lim1, Bumseok Kim3.   

Abstract

Mycotoxin deoxynivalenol (DON), a secondary metabolite produced by Fusarium fungi, is a contaminant in wheat, barley, and corn worldwide. It has been suggested that DON exhibits toxicity in various organs. Due to the lack of immunotoxicity data for DON, we investigated the differential immunomodulatory effects of DON in mice. DON was orally administered to female BALB/c mice at a dose of 0, 0.5, or 2mg/kg body weight for 14 days and various immunotoxicity tests were performed with standard protocols. The population of CD19(+) and CD11c(+) cells in the spleen and mesenteric lymph node (MLN) and of F4/80(+) cells in the spleen was significantly decreased in DON-treated mice, whereas the level of CD8(+) and CD4(+)CD25(+)Foxp3(+) cells in the spleen and CD4(+) T cells in MLN was significantly increased. In intra-epithelial lymphocytes (IELs) of the small intestine, the population of CD4 (+) and CD19(+) cells was increased but that of CD8(+) cells was decreased. Levels of CD4 (+) and CD8(+) cells were decreased in lamina propria lymphocytes (LPLs) of small intestine; however, the level of CD4(+) and CD8(+) lymphocytes was increased but that of CD19(+) cells was decreased in Peyer's patches lymphocytes (PPLs). Normalized expression of TLR4 in spleen, TLR9 in PPs, and TLR2, TLR3 and TLR4 in MLNs was significantly decreased, whereas expression of TLR5 and TLR9 was increased in spleen. The concentration of IgA and IgE was decreased and increased, respectively, in serum; however, the mucosal IgA level was significantly increased in the duodenum. Levels of IFN-γ, IL-2, IL-4, and IL-6 were significantly increased in serum. Furthermore, DON induced apoptosis in spleen, MLNs, and PPs, and DON-induced apoptosis was promoted by increased expression of Bax and decreased expression of Bcl-2. The autophagy genes Atg5 and Beclin-1 were up-regulated in spleen but down-regulated in MLN. After priming of the RAW 264.7 macrophage cell line with different TLR ligands, DON exposure differentially modulated IL-1β, IL-10, and TNF-α production. These results indicate that DON can cause various immunomodulatory effects in mice, creating a milieu that might allow invasion by other microorganisms.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; Cytokines; Deoxynivalenol; IgA; Immune cells

Mesh:

Substances:

Year:  2013        PMID: 23791694     DOI: 10.1016/j.toxlet.2013.05.656

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

1.  CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.

Authors:  Rui Li; Xizhen Xu; Chen Chen; Yan Wang; Artiom Gruzdev; Darryl C Zeldin; Dao Wen Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-11-11       Impact factor: 4.310

2.  Deoxynivalenol induces caspase-3/GSDME-dependent pyroptosis and inflammation in mouse liver and HepaRG cells.

Authors:  Xiaoxiao Mao; Jie Li; Xin Xie; Shuang Chen; Qiang Huang; Peiqiang Mu; Jun Jiang; Yiqun Deng
Journal:  Arch Toxicol       Date:  2022-08-04       Impact factor: 6.168

3.  The administration of diets contaminated with low to intermediate doses of deoxynivalenol and supplemented with antioxidants and binding agents slightly affects the growth, antioxidant status, and vaccine response in weanling pigs.

Authors:  Luca Lo Verso; Kristina Dumont; Martin Lessard; Karoline Lauzon; Chantale Provost; Carl A Gagnon; Younes Chorfi; Frédéric Guay
Journal:  J Anim Sci       Date:  2021-09-01       Impact factor: 3.338

Review 4.  A novel Peptide-binding motifs inference approach to understand deoxynivalenol molecular toxicity.

Authors:  Yousef I Hassan; Christena Watts; Xiu-Zhen Li; Ting Zhou
Journal:  Toxins (Basel)       Date:  2015-06-02       Impact factor: 4.546

5.  Evaluation of an oral subchronic exposure of deoxynivalenol on the composition of human gut microbiota in a model of human microbiota-associated rats.

Authors:  Manuel J Saint-Cyr; Agnès Perrin-Guyomard; Paméla Houée; Jean-Guy Rolland; Michel Laurentie
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

6.  The Effects of Deoxynivalenol and Zearalenone on the Pig Large Intestine. A Light and Electron Microscopy Study.

Authors:  Barbara Przybylska-Gornowicz; Bogdan Lewczuk; Magdalena Prusik; Maria Hanuszewska; Marcela Petrusewicz-Kosińska; Magdalena Gajęcka; Łukasz Zielonka; Maciej Gajęcki
Journal:  Toxins (Basel)       Date:  2018-04-04       Impact factor: 4.546

7.  Maternal Exposure Results in Long-Term Deoxynivalenol Persistence in Piglets' Plasma and Modulates the Immune System.

Authors:  Hana Štěpánová; Karolina Hlavová; Kamil Šťastný; Eduard Gopfert; Lenka Levá; Martin Faldyna
Journal:  Toxins (Basel)       Date:  2020-09-25       Impact factor: 4.546

8.  Nontoxic-dose deoxynivalenol aggravates lipopolysaccharides-induced inflammation and tight junction disorder in IPEC-J2 cells through activation of NF-κB and LC3B.

Authors:  Lei Ge; Ziman Lin; Guannan Le; Lili Hou; Xinru Mao; Shuiping Liu; Dandan Liu; Fang Gan; Kehe Huang
Journal:  Food Chem Toxicol       Date:  2020-08-30       Impact factor: 6.023

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.